James Beaulieu InspectorProfile

This FDA InspectorProfile is a report of relevant audit-related information on James Beaulieu, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Medical Devices & Rad Health.

Product Description

This InspectorProfile report is updated through Jan 2014 and lists James Beaulieu's inspections in 21 countries: United States, Ireland, Germany, Belgium, Switzerland, Costa Rica, Mexico, China, Italy, France, Korea (the Republic of), Sweden, New Zealand, Japan, United Kingdom, Finland, Taiwan, Korea, Republic Of (South), Bulgaria, Czech Republic, and Canada.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated James Beaulieu's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for James Beaulieu.

Product details

• James Beaulieu's metrics:
  • 483 issue rate, total inspections, total 483s
  • Most common citations (based on CFR), CFR description, and citation frequency
  • Total inspections, total 483s
  • Longest / shortest inspection in duration - all time, last year
  • Total warning letters
• Inspection details for each inspection (since 2000) James Beaulieu has conducted including:
  • Company, site inspected, duration of inspection
  • Co-inspectors Gregson Joseph, Alan Albrecht, Timothy Marrs, Marissa Steinhagen, Jaclyn Munsch, year of last co-inspection, number of co-inspections
  • If a 483 issued, and whether or not it resulted in a warning letter.

Note: The EIR and 483 documents are sold separately.